Suppr超能文献

金属蛋白酶组织抑制剂在人类动脉粥样硬化和再狭窄病变中的诱导及其对内皮细胞的促有丝分裂反应。

Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions.

作者信息

Tyagi S C, Meyer L, Kumar S, Schmaltz R A, Reddy H K, Voelker D J

机构信息

Department of Internal Medicine, Dalton Cardiovascular Research Center, University of Missouri-Health Sciences Center, Columbia, USA.

出版信息

Can J Cardiol. 1996 Apr;12(4):353-62.

PMID:8608454
Abstract

INTRODUCTION

Expression of extracellular matrix (ECM), including collagens and proteoglycans, is increased following atherosclerosis and restenosis.

OBJECTIVE

To understand the Mechanism of ECM induction and accumulation, the balance among neutral matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinase (TIMP) and activator (tissue plasminogen activator (tPA)) following atherosclerosis and restenosis was measured in human normal artery, and native atherosclerotic and restenotic lesions.

DESIGN AND RESULTS

Based on zymographic analysis, a correlation between the increase in latent and intrinsic MMP activity and an increase in the duration from first angioplasty to restenotic atherectomy was found, suggesting decreased MMP activity from normal tissue to restenotic tissue. ELISA was carried out to measure the level of TIMP. Inhibition of collagenase activity, against fluorescein-conjugated type I collagen degradation, by normal, de novo and restenotic extracts was determined. TIMP levels were found to be increased in restenotic lesions (0.38+/-0.04 ng/mL) compared with normal arterial tissue (0.27+/-0.05 ng/mL) and with tissue derived from de novo (0.30+/-0.02 ng/mL atherosclerotic lesions. Mitogenic activity of tissue extracts, against normal human heart endothelial (HHE) cells, was measured using acid phosphatase assay as the marker of cell number. Based on neutralizing antibody to TIMP, mitogenic activity was observed in restenotic tissue to HHE cells. Using plasminogen/gelatin zymographic analysis, no significant change was observed in the level of tPA in extracts from all three groups (i.e., 8.1+/-1.2, 8.7+/-0.6, and 8.6+/-0.3 (arbitrary unit) in normal, de novo and restenotic tissue, respectively).

CONCLUSIONS

These results suggest that accumulation of ECM in restenotic tissue following mechanical revascularization may in part be due to repression in MMP expression, and may be associated with increased level of TIMP and its mitogenic activity.

摘要

引言

动脉粥样硬化和再狭窄后,包括胶原蛋白和蛋白聚糖在内的细胞外基质(ECM)表达增加。

目的

为了解ECM诱导和积累的机制,在人类正常动脉、原发性动脉粥样硬化病变和再狭窄病变中,检测动脉粥样硬化和再狭窄后中性基质金属蛋白酶(MMP)、金属蛋白酶组织抑制剂(TIMP)和激活剂(组织型纤溶酶原激活剂(tPA))之间的平衡。

设计与结果

基于酶谱分析,发现潜在和内在MMP活性的增加与首次血管成形术至再狭窄动脉内膜切除术的持续时间增加之间存在相关性,这表明从正常组织到再狭窄组织MMP活性降低。采用酶联免疫吸附测定(ELISA)法检测TIMP水平。测定正常、原发性和再狭窄提取物对荧光素偶联的I型胶原降解的胶原酶活性抑制作用。发现再狭窄病变中的TIMP水平(0.38±0.04 ng/mL)高于正常动脉组织(0.27±0.05 ng/mL)和原发性动脉粥样硬化病变组织(0.30±0.02 ng/mL)。使用酸性磷酸酶测定作为细胞数量标记,检测组织提取物对正常人心脏内皮(HHE)细胞的促有丝分裂活性。基于针对TIMP的中和抗体,观察到再狭窄组织对HHE细胞有促有丝分裂活性。使用纤溶酶原/明胶酶谱分析,三组提取物中tPA水平均未观察到显著变化(即正常、原发性和再狭窄组织中分别为8.1±1.2、8.7±0.6和8.6±0.3(任意单位))。

结论

这些结果表明,机械性血运重建后再狭窄组织中ECM的积累可能部分归因于MMP表达受抑制,并且可能与TIMP水平升高及其促有丝分裂活性有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验